AGEN.NASDAQAgenus INC

SCHEDULE 13G/A: BlackRock Discloses 1.8% Stake in AGENUS INC Common Stock

Sentiment:

Schedule 13G Amendment


BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 1.8% beneficial ownership stake in AGENUS INC's common stock as of June 30, 2025.

Summary

  • BlackRock, Inc. reported beneficial ownership of 503,986 shares of AGENUS INC common stock.
  • This ownership represents 1.8% of the total class of AGENUS INC's common stock.
  • BlackRock, Inc. holds sole voting power over 501,763 shares and sole dispositive power over 503,986 shares.
  • No shared voting or dispositive power was reported.
  • The filing is an Amendment No. 1 to a previous Schedule 13G.
  • The filing confirms that BlackRock's interest in AGENUS INC common stock is less than five percent of the total outstanding common shares for any single person.

Sentiment

Score: 5

Explanation: The document is a factual regulatory filing disclosing ownership, with no inherent positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding AGENUS INC's future operations or financial performance.

Industry Context

This filing reflects a routine disclosure by a major institutional investor, BlackRock, Inc., regarding its passive ownership stake in AGENUS INC. It is a standard regulatory requirement for investors holding significant positions in publicly traded companies.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney UpdateBlackRock, Inc. executed a new Power of Attorney on January 21, 2025, revoking a previous one dated April 30, 2023. This new power of attorney authorizes specific individuals to execute and file documents related to ownership or control-person reporting requirements on behalf of BlackRock and its affiliates.2025-01-21This is an internal corporate governance update for BlackRock, Inc. to streamline its regulatory filing processes, not directly impacting AGENUS INC's corporate governance.

Stakeholder Impact

  • Shareholders: Provides transparency regarding a significant institutional investor's stake in AGENUS INC, which can influence market perception and trading activity.

Key Dates

DateDescription
1998-01-12Date of SEC Release No. 34-39538, referenced for disaggregation of beneficial ownership.
2023-04-30Date of the previously revoked Power of Attorney.
2025-01-21Date of execution for the current Power of Attorney.
2025-06-30Date of event which required the filing of this statement.
2025-07-16Date the Schedule 13G was signed by BlackRock, Inc.

Keywords

BlackRock, AGENUS INC, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.